Lrti Case Drug Study
Lrti Case Drug Study
Lrti Case Drug Study
Respiratory:
bronchospasm
GENERIC CLASSIFICATION MODE OF INDICATION ADVERSE ROUTE NURSING RESPONSIBILITIES
NAME/ ACTION EFFECT
BRAND
NAME
CEFUROXIME Therapeutic: anti-Interferes with Moderate to CNS: ORAL • Assess for infection (vital signs;
Zinnat infective bacterial cell- severe infections, headache, appearance of wound, sputum,
urine, and stool; WBC) at
wall synthesis including those of hyper activity, beginning and during therapy.
Pharmacologic: and division by skin, bone, joints, hypertonia
second-generation binding to cell urinary or GI: • Before initiating therapy, obtain
cephalosporin wall, causing respiratory tract, pseudomembr a history to determine previous
cell to die. gynecologic anous colitis, use of and reactions to
penicillines or cephalosporins.
Active against infections, and diarrhea, Person with a negative history of
gram-negative septicemia. abdominal penicillin sensitivity may still
and gram- pain, nausea, have an allergic response.
positive vomiting
bacteria, with GU: • Obtain specimens for culture
and sensitivity before initiating
expanded hematuria, therapy. First dose may be given
activity against renal before receiving results.
gram-negative dysfunction
bacteria. Hemat: • Observe patients for s/s of
anaphylaxis (rash, pruritus,
Exhibits hemorrhage,
laryngeal edema, wheezing).
minimal hemolytic Discontinue the drug and notify
immunosuppre anemia physician or other heath care
ssant activity. Metabolic: professional immediately if these
hyperglycemia symptoms occur. Keep
epinephrine, an antihistamine,
Misc:
and resuscitation equipment
anaphylaxis, close by in the event of an
allergic anaphylactic reaction.
reaction
GENERIC CLASSIFICATION MODE OF INDICATION ADVERSE ROUTE NURSING RESPONSIBILITIES
NAME/ ACTION EFFECT
BRAND
NAME